A detailed history of First Long Island Investors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, First Long Island Investors, LLC holds 139,696 shares of ABBV stock, worth $24.7 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares
139,696
Previous 140,575 0.63%
Holding current value
$24.7 Million
Previous $24.1 Million 14.42%
% of portfolio
2.2%
Previous 2.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $144,015 - $175,211
-879 Reduced 0.63%
139,696 $27.6 Million
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $425,362 - $496,728
-2,748 Reduced 1.92%
140,575 $24.1 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $491,606 - $560,139
-3,076 Reduced 2.1%
143,323 $26.1 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $373,859 - $421,053
-2,717 Reduced 1.82%
146,399 $22.7 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $73,073 - $84,593
547 Added 0.37%
149,116 $22.2 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $134,762 - $167,703
1,017 Added 0.69%
148,569 $20 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $3.21 Million - $3.69 Million
-22,181 Reduced 13.07%
147,552 $23.5 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $353,520 - $423,963
-2,556 Reduced 1.48%
169,733 $27.4 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $188,699 - $216,425
-1,406 Reduced 0.81%
172,289 $23.1 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $3.79 Million - $4.81 Million
-27,505 Reduced 13.67%
173,695 $26.6 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $3.44 Million - $4.27 Million
-26,057 Reduced 11.47%
201,200 $32.6 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $1.21 Million - $1.53 Million
11,220 Added 5.19%
227,257 $30.8 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $831,728 - $944,137
7,817 Added 3.75%
216,037 $23.3 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $869,771 - $968,975
-8,267 Reduced 3.82%
208,220 $23.5 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $369,916 - $407,233
-3,616 Reduced 1.64%
216,487 $23.4 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1.35 Million - $1.82 Million
16,790 Added 8.26%
220,103 $23.6 Million
Q3 2020

Nov 17, 2020

BUY
$85.91 - $100.83 $1.35 Million - $1.59 Million
15,724 Added 8.38%
203,313 $17.8 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $124,949 - $167,200
-1,703 Reduced 0.9%
187,589 $18.4 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $3.75 Million - $5.68 Million
58,077 Added 44.26%
189,292 $14.4 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.04 Million - $1.3 Million
14,356 Added 12.28%
131,215 $11.6 Million
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $3,778 - $4,543
-60 Reduced 0.05%
116,859 $8.85 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $89,352 - $114,212
1,360 Added 1.18%
116,919 $8.5 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $2.68 Million - $3.15 Million
-34,727 Reduced 23.11%
115,559 $9.31 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $6,228 - $7,680
-80 Reduced 0.05%
150,286 $13.9 Million
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $461,887 - $513,473
5,195 Added 3.58%
150,366 $14.2 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $1.17 Million - $1.39 Million
-13,041 Reduced 8.24%
145,171 $13.5 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $2.89 Million - $3.87 Million
-31,392 Reduced 16.56%
158,212 $15 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $297,966 - $326,744
-3,327 Reduced 1.72%
189,604 $18.3 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.22 Million - $1.56 Million
17,497 Added 9.97%
192,931 $17.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
175,434
175,434 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Long Island Investors, LLC Portfolio

Follow First Long Island Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Long Island Investors, LLC with notifications on news.